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ABSTRACT 
Introduction and objective: The hepatitis B virus has a high global prevalence, with a strong 
impact on public health, which justifies surveillance strategies and prevention of possible 
diseases. The risk of exposure to the virus among health students and health professionals is a 
major concern, showing that public adherence to biosafety measures is low. The objective was 
to evaluate knowledge, immunization against hepatitis B and use of biosafety measures by 
health students at a university in the interior of Minas Gerais. Methods: This is a cross-
sectional, descriptive study with self-administered questionnaire composed of 
sociodemographic variables and questions about biosafety. Results: Of the 540 students who 
participated in the study, 37.2% declared no knowledge about biosafety, and of these, 28.9% 
were not vaccinated against hepatitis B; 32.4% of the students considered them not exposed to 
biosafety hepatitis B virus, and of these 25.7% were not vaccinated. Still, the study showed that 
13.3% of the students did not use gloves and of these 41.7% were not vaccinated. Conclusion: 
There are gaps in the knowledge and use of biosafety measures, among them, the failure of 
immunization against hepatitis B. Thus, the adoption of policies of permanent education with 
systematic inclusion of biosafety and mechanisms that will guarantee these students’ 
immunization is necessary. 
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Justificativa e Objetivo: O vírus da hepatite B tem alta prevalência mundial, com forte impacto 
na saúde pública, o que justifica as estratégias de vigilância e prevenção dos possíveis agravos. 
O risco da exposição ao vírus entre os estudantes e profissionais de saúde constitui uma grande 
preocupação, mostrando-se baixa a adesão desse público às medidas de biossegurança. O 
objetivo foi avaliar o conhecimento, imunização contra hepatite B e uso das medidas de 
biossegurança por estudantes da área da saúde em uma universidade no interior de Minas 
Gerais, Brasil. Métodos: Estudo transversal, descritivo, com aplicação de questionário, de 
autopreenchimento, a estudantes da área da saúde, composto por variáveis sociodemográficas 
e referentes ao tema biossegurança. Resultados: Dentre os 540 estudantes que participaram do 
estudo, 37,2% declararam não ter conhecimento sobre biossegurança, e desse total, 28,9% não 
foram vacinados contra a hepatite B, 32,4% dos estudantes consideraram que não estavam 
expostos ao vírus da hepatite B, e desses, 25,7% não eram vacinados. Ainda o estudo mostrou 
que 13,3% dos estudantes não usavam luvas e, destes, 41,7% não eram vacinados. Conclusão: 
Verificou-se que existem lacunas em relação ao conhecimento e uso das medidas de 
biossegurança, entre estas, a falha da imunização contra hepatite B. Neste sentido, faz-se 
necessária a adoção de políticas de educação permanente com inclusão sistemática do tema 
biossegurança e adoção de mecanismos que garantirão a imunização desses estudantes. 




Justificación y Objetivos: El virus de la hepatitis B tiene alta prevalencia mundial, con fuerte 
impacto en la salud pública, lo que justifica las estrategias de vigilancia y prevención de los 
posibles agravios. El riesgo de exposición al virus entre los estudiantes y los profesionales de 
la salud constituye una gran preocupación por la baja adhesión de este público a las medidas de 
bioseguridad. El objetivo fue evaluar el conocimiento, inmunización contra la hepatitis B y el 
uso de las medidas de bioseguridad por estudiantes del área de la salud en una universidad en 
el interior de Minas Gerais, Brasil. Métodos: Estudio transversal, descriptivo, con cuestionario 
de autorrelleno aplicado a estudiantes del área de salud compuesto por variables 
sociodemográficas y sobre el tema bioseguridad. Resultados: Entre los 540 estudiantes que 
participaron en el estudio, el 37,2% declararon no tener conocimiento sobre bioseguridad, y de 
ese total, el 28,9% no fueron vacunados contra la hepatitis B, el 32,4% de los estudiantes 
consideraron que no estaban expuestos al virus de la hepatitis B, y de estos el 25,7% no eran 
vacunados. Aún el estudio mostró que el 13,3% de los estudiantes no usaban guantes y, de estos, 
un 41,7% no eran vacunados. Conclusión: Se verificó que existen lagunas en relación al 
conocimiento y uso de las medidas de bioseguridad, entre estas, el fallo de la inmunización 
contra la hepatitis B. En este sentido, se hace necesaria la adopción de políticas de educación 
permanente con la inclusión sistemática del tema bioseguridad y la adopción de medidas que 
garantizarán la inmunización de esos estudiantes. 




Infection by the Hepatitis B Virus (HBV) is the main cause of chronic hepatitis, liver 
cirrhosis and hepatocellular carcinoma, and its transmission occurs by sexual contact, 
contaminated material used in health care or aesthetics services, blood transfusion and 
 
  
derivatives, as well as by vertical transmission.1-3 In health care settings, the incidence rate of 
HBV infection is high, mainly because of the risk associated with occupational exposure.4 
HBV was responsible for 1.34 million deaths in 2015, which is compatible with the 
deaths caused by tuberculosis and HIV. According to the Pan American Health Organization, 
viral hepatitis is considered a major public health challenge.5,6 The main strategies used to fight 
HBV infection include (i) the vaccination of students and health professionals, (ii) the use of 
Personal Protective Equipment (PPE) and (iii) post-exposure management.5,7 However, the 
population does not meet the recommendations and most vaccinated individuals do not follow 
up on immunization through laboratory tests, which confirm or not the effectiveness of 
immunization, as serum markers of immunity (anti-HBs) and, or the assessment of presence of 
HBV surface antigen (HBsAg) and the quantification of the virus in the bloodstream (viral load 
/ HBV-DNA).2 
The number of people infected with HBV is estimated at 257 million.5 The prevalence 
of hepatitis B is highest in the Western Pacific Region and Africa, where 6.2% and 6.1%, 
respectively, of the adult population are infected. In Eastern Mediterranean, Southeast Asia and 
Europe, it is estimated that 3.3%, 2.0% and 1.6%, respectively, of the general population are 
infected.6 In Ethiopia, a study carried out with health students showed that despite the majority 
(> 80.0%) reporting knowledge about the infectious process, transmission and prevention 
concerning HBV, only 50% performed safe practices regarding occupational risk of infection.8 
Similarly, in a study done with dentistry students, it was observed that only 45.0% of the 
students were vaccinated, although 86% of them showed knowledge about the HBV infection 
process.6 Similar results were found in studies conducted in Australia, Iran and Nigeria.1-3  
In Brazil, the Secretariat of Health Surveillance recorded the occurrence of 218,257 
cases of HBV infections in 2017, with an increase from 6.5 to 11.9 cases per 100,000 inhabitants 
compared to 2016.9 Among medical students, Antunes et al. found that 55.2% do not know the 
universal precautions and, worryingly, 13.89% were not vaccinated against HBV, with 10% 
declaring some type of accident with biological risk.10  
The risk of exposure to HBV among health students and professionals is a major 
concern, and different studies show that adherence to safety measures is low and some 
individuals are even unaware of it.10 Among the different accidents reported by health service 
professionals, injury from sharps is the most prevalent ,which it is a form of possible exposure 
to HBV.2,8 Thus, the present study aimed to assess knowledge, immunization against hepatitis 






A cross-sectional, descriptive study was conducted at a university in the interior of 
Minas Gerais, Brazil, from November 2017 to April 2018, with all students regularly enrolled 
in the Nursing, Pharmacy and Physical therapy courses at the School of Biological Sciences 
and Health (FCBS) and Medicine at the Diamantina Medical School (FAMED). Students 
enrolled in the first period of these courses were excluded from the study. 
The students answered a structured, self-administered and voluntary questionnaire. The 
approach was done during the students’ regular classes with the prior authorization of the 
professor, and reading and signing the Free Informed Consent Term (ICF). Three attempts were 
made to collect the data. The time taken to complete the questionnaire was approximately 20 
minutes. It evaluated (i) sociodemographic variables (age group; gender; period of enrollment 
in the course) and (ii) the topic of biosafety (knowledge and use of biosafety measures; report 
on immunization against hepatitis B; risk of exposure to HBV and HIV; Work with 
contaminated material; Accident reporting; Disposal of sharps; Use of personal protective 
equipment). 
Data statistical analysis was performed using EpiData version 3.1 and Statistical 
Package for the Social Sciences (SPSS) 22.0 programs. The absolute and relative frequencies 
of the variables were calculated, and Pearson’s chi-square test was performed to assess the 
association between the data. The level of significance considered was 5% (p < 0.05). 
 The project was approved by the Research Ethics Committee of UFVJM, Diamantina, 
Minas Gerais, under opinion number 1.906.279, CAAE 61212816.7.0000.5108. This study was 
developed in compliance with the ethical precepts of research. 
 
RESULTS 
 Of a total of 874 students regularly enrolled in the Nursing, Pharmacy, Physical therapy 
and Medicine courses, 85.4% (746) were eligible and 14.6% (128) did not participate in the 
study for attending the first period of the course, respecting the one exclusion criteria. Among 
those eligible, 72.4% (540) participated in the survey and answered the questionnaire, where 
16.3%, 24.3%, 29.4% and 30% belonged to nursing, pharmacy, physical therapy and medicine 
courses, respectively. Considering sociodemographic variables, 76.1% (411) of the students 
were female and aged 21-30 years (66.9%) (Table 1). 
Regarding immunization against hepatitis B, the number of unvaccinated students 
varied, with 23.3% (37), 21.4% (28) and 18.5% (30) of students from Physical therapy, 
 
  
Pharmacy and Medicine courses, respectively, not being vaccinated. The lowest prevalence was 
observed among nursing students (12.5%), in which only 11 students out of a total of 88 were 
not vaccinated (Figure 1).  
As for gender, a higher percentage of male students (26.4%) was not vaccinated 
compared to female students (17.5%). The percentage of immunization between age groups 
ranged from 71.4 to 84.8%, with a higher value for the group with the highest students 
concentration (21-30 years). 
As for course period, most students (19.6%) were in the second while the minority 
(14.1%) was in the ninth period (Table 1). The highest percentage of vaccinated students was 
found in the last periods of the courses (82.6-95.6%), whereas the highest percentage of non-























Table 1. Prevalence of students vaccinated against hepatitis B, regarding sociodemographic 
variables, Diamantina / MG, Brazil, 2017-2018. 
































#Pearson’s chi-square.*Fisher’s exact test. 
 
Regarding basic knowledge about biosafety measures, 37.2% (201) of the students 
declared no knowledge of the measures and, of this total, 28.9% were not vaccinated against 
hepatitis B (Table 2). For those who declared knowledge (62.8%), a smaller percentage (14.2%) 
was not vaccinated against HBV. Considering the use of biosafety measures (Table 2), 23.3% 
(126) do not use them and, of these, 34.1% (43) were not vaccinated. Among those who used 
the measures (45.4%), the percentage of non-vaccinated fell to 9.8% (24). 
A total of 62.6% of the participants did not perform a test to verify the effectiveness of 
immunization against hepatitis B or did not remember (24.4%) (Table 2). Of the total number 
of students who did not evaluate immunization, 82.5% were vaccinated (279). Even among the 
unvaccinated, 32.6% of the individuals answered “I don’t remember” to the same question. 
A total of 32.4% of the students considered themselves unexposed to the HBV or HIV 
virus during the course, of which 25.7% (45) were not vaccinated against HBV. When asked if 
they work with contaminated material (Table 2), 64.6% (349) answered “no” and, of these, 
23.5% (82) were not vaccinated. 
Of the total number of students, 90.4% (488) said they did not use cell phones or 
drinking fountains with gloves on (Table 2). Regarding injury with sharps, 11.5% (62) of the 
  (n= 540) (n= 434) (n= 106) 
Gender             0.02# 
Male 129 23.9 95 73.6 34 26.4 
 
Feminine 411 76.1 339 82.5 72 17.5   
Age range  
      
0.00* 
18-20 years 165 30.6 118 71.5 47 28.5 
 
21-30 years 361 66.9 306 84.8 55 15.2 
 
> 30 years 14 2.6 10 71.4 4 28.6   
Current period 
      
0.00# 
2⁰ 106 19.6 73 68.9 33 31.1 
 
3⁰ 53 9.8 40 75.5 13 24.5 
 
4⁰ 63 11.7 43 68.3 20 31.7 
 
5⁰ 65 12.0 55 84.6 10 15.4 
 
6⁰ 76 14.1 68 89.5 8 10.5 
 
7⁰ 51 9.4 44 86.3 7 13.7 
 
8⁰ 58 10.7 49 84.5 9 15.5 
 
9⁰ 23 4.3 19 82.6 4 17.4 
 
10⁰ or greater 45 8.3 43 95.6 2 4.4   
 
  
students suffered accidents with some material and 4.1% (22) stated that they had already 
splashed blood or fluids in their eyes. Regarding the disposal of needles or other sharp material, 
13.3% (72) reported discarding sharps in plastic bags. For these questions, there was no 
statistically significant association (p > 0.05) concerning the prevalence of vaccinated or 
unvaccinated. 
This part of the questionnaire ended with the question “do you judge the information 
you receive about biosafety sufficient” (Table 2) and 67% (362) answered “no”. Of these, only 
22.7% (82) were vaccinated against HBV, while among those who felt the information was 
sufficient (33.0%), 86.5% (154) were vaccinated. 
 
  
Table 2. Prevalence of students vaccinated against hepatitis B, regarding basic knowledge about biosafety measures, Diamantina / MG, 
Brazil, 2017-2018. 





% p Value 
  (n= 540) (n= 434) (n= 106) 
Know the biosafety measures             0.00 
Yes 339 62.8 291 85.8 48 14.2  
No 201 37.2 143 71.1 58 28.9   
Makes use of biosafety measures       0.00 
Yes 245 45.4 221 90.2 24 9.8  
No 126 23.3 83 65.9 43 34.1  
Sometimes 169 31.3 130 76.9 39 23.1  
Tested to see if you were immunized against hepatitis B             0.00 
Yes 70 13 66 94.3 4 5.7  
No 338 62.6 279 82.5 59 17.5  
I do not remember 132 24.4 89 67.4 43 32.6   
Do you think you are exposed to hepatitis B and HIV       0.01 
Yes 365 67.6 304 83.3 61 16.7  
No 175 32.4 130 74.3 45 25.7  
Works with material that may be contaminated             0.01 
Yes 191 35.4 167 87.4 24 12.6  
No 349 64.6 267 76.5 82 23.5   
Answer your cell phone or use a drinking fountain while wearing gloves       0.56 
Yes 22 4.1 16 72.7 6 27.3  
No 488 90.4 395 80.9 93 19.1  
Sometimes 30 5.6 23 76.7 7 23.3  
Have you ever had an accident with sharps             0.33 
Yes 62 11.5 47 75.8 15 24.2  
No 478 88.5 387 81.0 91 19.0   
Have you ever spilled blood or fluids in your eyes or mouth       0.86 
Yes 22 4.1 18 81.8 4 18.2  
No 518 95.9 416 80.3 102 19.7   
 
  
Do you discard a needle or other sharp material in plastic bags?             0.27 
Yes 72 13.3 53 73.6 19 26.4  
No 435 80.6 355 81.6 80 18.4  
Sometimes 33 6.1 26 78.8 7 21.2   
Judges the information about biosafety received sufficient       0.01 
Yes 178 33.0 154 86.5 24 13.5  
No 362 67.0 280 77.3 82 22.7   
Pearson’s chi-square.  
 
  
Table 3 presents the results for using four different PPEs. It was observed that most 
students (86.7 and 94.8%, respectively) wear gloves or a lab coat/apron, with a high prevalence 
of immunized people (83.8 and 81.3%, respectively). Among the 72 (13.3%) students who did 
not wear gloves in academic practices, 41.7% (30) were not vaccinated. The percentage of 
students who did not wear a mask and glasses was 61.5% (332) and 82.4% (445), respectively, 
with approximately 23% of them not being immunized (Table 3). 
 
Table 3. Prevalence of students vaccinated against hepatitis B, regarding the use of personal 
protective equipment, Diamantina / MG, Brazil, 2017-2018. 





%  p Value 
  (n= 540) (n= 434) (n= 106) 
Gloves             0.00# 
Yes 468 86.7 392 83.8 76 16.2  
No 72 13.3 42 58.3 30 41.7   
Mask 
      0.01
# 
Yes 208 38.5 182 87.5 26 12.5  
No 332 61.5 252 75.9 80 24.1  
Glasses             0.00* 
Yes 95 17.6 88 92.6 7 7.4  
No 445 82.4 346 77.8 99 22.2   
Apron or lab coat 
      0.02
# 
Yes 512 94.8 416 81.3 96 18.8  
No 28 5.2 18 64.3 10 35.7   
#Pearson’s chi-square. *Fisher’s exact test. 
 
DISCUSSION 
 Vaccination against hepatitis B is essential for health students security when starting 
their activities in practical classes and/or internships. In the USA, in 2002, the Center for 
Disease Control and Prevention reaffirmed the guideline that highlighted the ethical 
commitment of universities and health institutions to carry out active surveillance of students 
and professionals before the beginning of curricular activities in healthcare establishments.11 In 
Brazil, according to Ordinance 597 of the Ministry of Health, educational institutions have a 
fundamental role in monitoring the vaccination status of their students, making HBV 
vaccination mandatory as a basic requirement for enrollment in educational institutions.12 Thus, 
administrative policies in educational institutions must ensure that students receive the three 
doses of the vaccine, either by making them available in the university environment or by 




 In this study, the majority of students (80.4%) stated that they had been immunized 
against HBV. However, the number of doses fulfilled in the vaccination schedule (3 doses) was 
not questioned. A previous study found that although 68.4% of medical students at a Brazilian 
public university were vaccinated, only 48.9% received the three necessary doses.13 Similarly, 
other authors found that while 93.9% of students reported vaccination upon entering medical 
school in Saudi Arabia, only 59.5% had completed the three-dose schedule.14 Health 
professionals from the municipal administration of an Ethiopian city reported that only 10% of 
respondents had received one or more doses of hepatitis B vaccination and 69.2% declared 
some type of occupational accident with blood exposure to unprotected mucous membranes 
and skin.15  
 When asked about the test to check the effectiveness of HBV immunization, most of the 
students declared that they had not done it (62.6%) or did not remember having done it (24.4%). 
After the completion of the three doses, a serological test is necessary to evaluate 
seroconversion (anti-HBsAG ≥ 10 IU / ml), and one of the conducts for a negative result is, 
after the third dose, to repeat the schedule (zero, one and six months).16 
The highest percentage of students interviewed was female (76.1%), with the majority 
being vaccinated (82.5%), with a predominance of the 21 to 30 age group. The study by Souza 
and Teixeira carried out with medical students also found a predominance of participants who 
declared themselves to be female (59.7%), but with a lower prevalence of vaccination among 
them (49.6%) and an average age of 22, 8 years.13 Considering the report of accidents between 
health students and health professionals, it was found that 70% of the individuals declared 
themselves to be female, with an average of 21 to 30 years of age.17 The higher percentage of 
vaccination among female students can be explained by the lower demand for health services 
among male individuals.18 The prevalence of vaccinated students in the age group of 21 to 30 
years is justified by the history of implementation of the vaccine schedule against HBV in 
Brazil. The hepatitis B recombinant DNA vaccine appeared in 1986and was gradually 
implemented for children under 20 in Brazil, reaching 30% of this population in 2001, 30% in 
2002 and 40% in 2003.19 
Considering the biosafety measures, most students claimed to know them (62.8%) and 
use them (45.4%). However, a large number of individuals stated that they were not immunized 
against HBV. The percentage of students immunized increased over the periods, probably 
because the greater contact with professional classes alerts them to the need to comply with the 
preventive vaccination schedule. Knowing the risks of the environment in which the work is 
 
  
carried out, mainly related to hepatitis B, a disease of rapid seroconversion, minimizes exposure 
to this virus, HIV and other biological agents that are related to the risks of practical activities.20 
When asked whether or not they were at risk of exposure to HBV and HIV viruses 
32.4% believed they were not exposed, with the prevalence of non-vaccinated among them 
being considerable (25.7%). In similar studies evaluating biosafety education in clinical 
analysis laboratories, it was observed that institutional support for the permanent training of 
professionals provides safe practices with the reduction of accidents at work.21 A study with 
dentistry students at the same institution present study is focusing on, found that 11.5% and 
17.9% of students did not use biosafety measures and full use of PPE, respectively, even though 
they knew biosafety measures.22 These authors, similarly to the present study (67%), observed 
that a large part of the students (48.7%) considered teaching on the topic of biosafety 
insufficient during academic training. 
Accidents with sharps are especially important because of greater exposure to HBV. 
There was a worrying rate (11.5%) of accidents with sharps among unvaccinated students, 
which are generally justified due to less practical experience, nervousness and insecurity during 
procedures.23 A study carried out with health professionals found that 40.5% suffered accidents 
with sharps, of which 14.6% were not vaccinated.24 
Although PPE is, in the first analysis, fundamental equipment for preventing accidents 
with sharps, it appears that there is a lack of knowledge regarding their use.23 In the present 
study, there was a high prevalence of students who declared no use of mask and glasses during 
academic activities that require the use of the respective PPE. Ignoring this equipment increases 
the risk of contamination and aggravates work accidents. Among these individuals, the 
prevalence of non-vaccinated against hepatitis B was high, that is, individuals highly vulnerable 
to accidental exposure, which, similarly to the present study (approximately 23%), reached a 
prevalence of 28.6% among medical students in Ethiopia.24  
In the learning process, professors are essential in teaching accident prevention. The 
topic of biosafety must be worked systematically in existing subjects in the curricula of the 
courses from the initial periods, so there is permanent education. Students who are exposed to 
infection must comply with the HBV vaccination schedule. Immunization protects the student 
and is a precaution for the patient, since the student can also transmit infections and cause health 
problems to them.25 
As this is a cross-sectional study, it was not possible to establish a relationship between 
cause and consequences. Although students provided information in the self-report, because of 
 
  
memory bias, the data may not match the real situation of seroconversion. Therefore, further 
studies should be carried out with the execution of a seroconversion test. 
This study addressed a relevant public health problem that must be discussed and 
explored in the academic community. There was a scarcity of data found on biosafety measures, 
both regarding research studies and the teaching of this topic in health courses. At the local 
university, only one study on biosafety was found among dentistry students.22 Therefore, the 
present work contributed to the situational diagnosis by covering other courses in the health 
area, enabling actions based on real data to allow changing this scenario. 
The diagnosis made brought a scientific basis that allowed to identify gaps concerning 
knowledge and use of biosafety measures, among them, the failure of immunization against 
hepatitis B among students. Thus, the adoption of permanent education policies with a 
systematic inclusion of the topic of biosafety in the curricula of health courses is necessary. 
Teachers should also be encouraged to carry out periodic training on the topic. The use of 
mechanisms that will guarantee the immunization of these students as a mandatory action for 
entering university is still necessary. 
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